Fiera Capital Corp Sells 46,486 Shares of CME Group Inc. $CME

Fiera Capital Corp trimmed its holdings in CME Group Inc. (NASDAQ:CME) by 1.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,744,106 shares of the financial services provider’s stock after selling 46,486 shares during the quarter. CME Group accounts for about 2.4% of Fiera Capital Corp’s portfolio, making the stock its 9th biggest holding. Fiera Capital Corp’s holdings in CME Group were worth $741,430,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in CME. Norges Bank bought a new stake in CME Group during the second quarter worth approximately $1,571,447,000. Mawer Investment Management Ltd. boosted its stake in shares of CME Group by 107.2% during the 3rd quarter. Mawer Investment Management Ltd. now owns 1,502,752 shares of the financial services provider’s stock worth $406,029,000 after acquiring an additional 777,571 shares in the last quarter. Viking Global Investors LP bought a new stake in shares of CME Group during the 2nd quarter worth $164,648,000. Vanguard Group Inc. grew its holdings in shares of CME Group by 1.5% in the 2nd quarter. Vanguard Group Inc. now owns 35,176,376 shares of the financial services provider’s stock worth $9,695,313,000 after acquiring an additional 532,549 shares during the last quarter. Finally, Magellan Asset Management Ltd raised its position in shares of CME Group by 131,625.5% during the second quarter. Magellan Asset Management Ltd now owns 486,067 shares of the financial services provider’s stock worth $133,970,000 after purchasing an additional 485,698 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Buying and Selling

In other CME Group news, Director William R. Shepard acquired 251 shares of the business’s stock in a transaction that occurred on Tuesday, December 30th. The shares were purchased at an average price of $278.37 per share, with a total value of $69,870.87. Following the completion of the transaction, the director owned 258,710 shares in the company, valued at $72,017,102.70. The trade was a 0.10% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Terrence A. Duffy sold 25,000 shares of CME Group stock in a transaction that occurred on Thursday, December 11th. The shares were sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the completion of the sale, the chief executive officer owned 65,804 shares of the company’s stock, valued at $17,737,468.20. This trade represents a 27.53% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.30% of the stock is currently owned by corporate insiders.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME will launch round‑the‑clock trading for crypto futures and options on May 29, expanding access for institutional clients and reducing timing gaps with spot crypto venues. PR Newswire: CME Group to Launch 24/7 Cryptocurrency Futures and Options Trading on May 29
• Positive Sentiment: Company cites record crypto notional volume and rising ADV in 2025–2026, suggesting the 24/7 shift could raise trading volumes and transaction-related revenue. Blockonomi: CME Group Set to Offer Round-the-Clock Crypto Futures Trading in May
• Positive Sentiment: Market commentary and trade desks are highlighting CME as a beneficiary of volatility-driven flows and reliable income generation, with some analysts/strategists listing CME among top picks for navigating market swings. Seeking Alpha: My Picks To Monetize Today’s Market Chaos
• Neutral Sentiment: Analyst consensus remains a “Hold,” reflecting tempered expectations despite product expansion; that keeps upside tied to execution and volume pickup. American Banking News: CME Group Receives Consensus Recommendation of “Hold”
• Neutral Sentiment: Short‑interest reporting for mid‑February shows effectively zero/unclear reads (data noise), so there’s no clear short‑base pressure implied by the available short‑interest figures.
• Negative Sentiment: The 24/7 rollout is pending regulatory review and requires smooth operational implementation; delays, regulatory objections, or execution issues (clearing/reporting during expanded hours) could weigh on sentiment if they occur. Cointelegraph: CME targets May launch for 24/7 crypto derivatives trading

CME Group Trading Up 0.4%

CME Group stock opened at $303.91 on Friday. CME Group Inc. has a 12 month low of $246.68 and a 12 month high of $309.35. The company has a quick ratio of 1.02, a current ratio of 1.03 and a debt-to-equity ratio of 0.12. The stock has a market cap of $109.59 billion, a P/E ratio of 27.23, a P/E/G ratio of 3.54 and a beta of 0.27. The company’s fifty day simple moving average is $282.49 and its 200-day simple moving average is $274.70.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.75 by $0.02. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The business had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same period last year, the company earned $2.52 earnings per share. CME Group’s quarterly revenue was up 8.1% compared to the same quarter last year. As a group, sell-side analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, March 26th. Investors of record on Tuesday, March 10th will be paid a $1.30 dividend. This represents a $5.20 annualized dividend and a dividend yield of 1.7%. The ex-dividend date of this dividend is Tuesday, March 10th. This is a positive change from CME Group’s previous quarterly dividend of $1.25. CME Group’s dividend payout ratio (DPR) is presently 44.80%.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on CME shares. TD Cowen lifted their price target on CME Group from $305.00 to $328.00 and gave the stock a “buy” rating in a research note on Thursday, February 5th. Rothschild & Co Redburn lifted their target price on shares of CME Group from $300.00 to $333.00 and gave the stock a “neutral” rating in a research report on Thursday, February 12th. Deutsche Bank Aktiengesellschaft boosted their price target on shares of CME Group from $312.00 to $316.00 and gave the company a “buy” rating in a report on Thursday, February 5th. Morgan Stanley raised their price objective on shares of CME Group from $319.00 to $340.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Finally, Royal Bank Of Canada lifted their price objective on shares of CME Group from $295.00 to $302.00 and gave the stock a “sector perform” rating in a research report on Thursday, February 5th. Nine analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $299.53.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.